February 2013

PharmaTrax

January 28, 2014

Pipelines are Shifting to Biotech Drugs Trending Now: Large molecules currently represent a dominant share of sales. The pharmaceutical industry, especially big pharma, has dramatically shifted its R&D focus from its historical concentration on small molecule drugs to include a rapidly increasing number of biotechnology products, according to a newly completed analysis from the Tufts […]

Clinical Nurse Educators: Driving Diagnosis, Prescribing, and Adherence

January 28, 2013

Clinical Nurse Educators: Driving Diagnosis, Prescribing, and Adherence Pete Megronigle, VP, Head of Health Management Solutions, ­Quintiles Faced by a broad array of challenges — from healthcare reforms to evolving practice dynamics — physicians have little time to spend with patients, and still less for biopharma sales representatives. This time pressure can limit a healthcare […]

Medical Affairs Outsourcing

January 28, 2013

Medical Affairs Outsourcing What are the top trends/reasons that have impacted the discipline of medical affairs and its function within the biopharmaceutical, medical device, and diagnostics industries and why is outsourcing of this function so desirable? The medical affairs function is increasingly playing a more vital role within today’s pharmaceutical, biotechnology, medical device, and diagnostic […]

SHOWCASE FEATURE: Outsourcing: Outsourcing For Efficiency

January 28, 2013

Outsourcing for Efficiency For many sponsor companies in the life-sciences industry engaging with outsourcing partners — from the clinic to the market — is imperative if they want to drive efficiencies in time, money, and personnel as well as innovation. Life-sciences companies can reap the many advantages and benefits of outsourcing, including cost-savings, increased market […]

C-Suite: Specialty Pharma

January 28, 2013

Specialty Pharma Targeted Opportunities C-Suite: Specialty Pharma By Taren Grom The growing U.S. specialty pharmaceuticals market is comprised of more than 90 companies marketing more than 550 prescription pharmaceutical products, according to MCD Group, and dozens of therapeutic categories, including CNS disorders, pain management, men’s and women’s health, rare diseases, and urology. Robert Chioini CEO […]

Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences

January 28, 2013

Saudi Arabia: Oil Wealth Opens Doors to Health and Life Sciences By Kim Ribbink Its wealth, growing population, investment in health and the life sciences, and high rates of diseases such as diabetes, make Saudi Arabia an exciting market for pharma companies. Saudi Arabia is perhaps best known for its oil, and the concomitant wealth […]

Mining for Gold in Patient Communities

January 28, 2013

Mining for Gold in Patient Communities By Robin Robinson Companies find market research value from both public and private patient­ communities. During a recent social media summit with patient community members who live with diabetes, Roche discovered a vital piece of information that changed its marketing and improved its credibility within the patient community. According […]

Compliance with GCP

January 28, 2013

Compliance with GCP With more clinical trials being done outside the United States and an increased focus by regulators on patient safety, it’s critical for pharma companies to follow good clinical practices in their development programs. By Denise Myshko Regulators around the globe are requiring more data from pharmaceutical companies as part of their applications […]

The Cloud in Pharma Research

January 28, 2013

The Cloud in Pharma Research The cloud has the potential to bring more ­efficient data management to clinical research, but pharmaceutical companies are approaching source sharing cautiously. Web-based solutions for R&D are not new, but during the past few years, they have morphed into what many call “the cloud.” The cloud, in its simplest form, […]

Gone in 7 Seconds

January 28, 2013

Gone In 7 Seconds Marketers have two blinks of the eye to catch the attention of their potential audience. Multiple media delivery options, data-driven approaches, consensus-driven team processes, and the fear of regulatory backlash are just a few of the inkblots that can clutter the creative drawing board. The estimated time people give their attention […]

Gamification is Serious Business

January 28, 2013

Research and case studies from both the academic and healthcare space bring forth ample evidence that games can improve patient compliance and healthcare outcomes. But can they effectively be used for physician education, sales training, and brand marketing? Forward-thinking gamification experts believe they can. According to our experts, gamification has implications across the all industry […]

Last Word

January 25, 2013

Focus: Oncology Paul Hawthorne, VP and Head, Oncology Business Unit at Sanofi US Inc., talks about how the company is addressing unmet needs in cancer. At Sanofi Oncology the aim is to combat cancer in all its different forms by carrying out research on the different pathways ­involved in the development, growth, and propagation of […]

On the Calendar

January 25, 2013

Coming ATTRACTIONS The 2013 Pharmaceutical Market Research Group (PMRG) Annual National ­Conference, March 10-12, 2013, at the Gaylord National Hotel, National Harbor, M.D., will focus on the intrinsic value that an evolved healthcare marketing researcher must bring to today’s global brands and organization — value as a forward-thinking consultant, who not only provides the insight, […]

Talent Pool

January 25, 2013

Biotech Pool Dr. Michelle BERREY Chimerix Appoints CMO Chimerix, a biotechnology company developing orally available antiviral therapeutics, has named Michelle Berrey, M.D., chief medical officer. Before joining Chimerix, Dr. Berrey was chief medical officer at Pharmasset. Lindsay ROCCO Dendreon Appoints Lead for Corporate Communications Dendreon, a biotechnology company whose mission is to target cancer and […]

PharmaTrax

January 25, 2013

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Formulary Decision Makers Want Digital Resources from Pharma Companies Lose Revenue to Nonadherence Contract Sales to Grow KOL Advocacy is Critical Sidebar: Nonadherence Study Highlights Thought Leader Pool Shrinking as Compensation Rates Fall Big Pharma Embraces Biologics Other Market Insights… Generic Market Expected to Grow Therapeutic […]

Tools of the Trade

January 25, 2013

New electronic and web-based applications, sites, and technologies Trending Now: As trials become larger and more complex, enhancing efficiency and traceability of clinical trial inventory is critical. PharmaVigilant has released I-Accountability, a drug accountability system that efficiently tracks and controls drug inventory and randomization. As trials become larger and more complex, I-Accountability centralizes and automates […]

What’s New

January 25, 2013

New Healthcare-related Products, Services, and Companies Featured Briefs: Publicis Healthcare Communications Group Launches Publicis Health Media Havas Health Launches New Global Agency Group INC Research Expands Global Consulting Capabilities Cenduit Introduces New Clinical Trial Supply Simulation and Forecasting Service Janssen R&D Establishes Global Cross-Pharmaceutical Clinical Trial Investigator Databank AROUND THE GLOBE WHAT’S NEW Publicis Healthcare […]

Marketing Tips & Techniques

January 25, 2013

Marketing Tips & Techniques: Twitter Symplur and the Healthcare Hashtag Project Best Practices in Advancing ­Twitter Presence Sidebars: By the Numbers: Symplur Healthcare Hashtag Project Top 20 Pharma Twitter Accounts Using Twitter to Identify Key Stakeholders Trending Now: 130 million tweets can’t be wrong; our experts explore the benefits of using Twitter. Symplur and the […]

UpFront

January 25, 2013

Awards… BBK Receives Web Health Award CRA Executives Honored InVivo Co-Founder ­Receives Award Ogilvy Wins Four Finalist ­Certificates at the Global Awards Wolters Kluwer Wins KLAS Award INDUSTRY at Large Bristol-Myers Squibb ­Foundation Supports Returning ­Veterans Pharmaceutical R&D Costs Increase Biotech Predictions for 2013 Big Pharma Will Increasingly Tap M&A Podcasts Demystifying Routine Care Coverage […]

Letter from the Editor

January 25, 2013

The Games Companies Play Gamification is not necessarily new to the corporate world, but the technologies that are now available are elevating gaming methodologies to a new level. For those of us who grew up in the era of Pong and Atari home videogames, boy have we come a long way. Wii, which revolutionized home […]

FEEDBACK